Indonesia Banks - Limited easing liquidity

Banks NS EW 413 22nd Oct, 2024

Despite recent Bank Indonesia’s (BI) benchmark rate cut, funding costs may continue to inch higher – reflecting the generally tight liquidity in the banking system. Tight liquidity may likely persist in the medium term (2024-25) unless there are large inflows into the banking system. This could potentially translate into some upward loan repricing despite competition, partly because we think mid-to-smaller sized banks may find it increasingly difficult to compete as seen in recent bank-only results (i.e. slower loan growth than major banks). This could mitigate NIM risks for banks. And within the sector, we think major banks such as BBCA/BMRI/BBRI/BRIS are able to mitigate such risks better than others. Our top pick in the sector is BBCA; meanwhile in the syariah banking space, BRIS remains our top pick (despite its already premium valuation multiples relative to other major banks). 

In this note, we assess BI’s Open-Market-Operation (OMO) trends. In short, total OMO outstanding as of 17 Oct 2024 reached ~IDR1,000tr – returned to prior peak (in Jan-2022). However, as % of loans, it was at ~13% in Oct 2024, down from ~16% in Jan 2022. We also see changes in OMO composition towards more SRBIs (BI’s Rupiah Securities with tenor ranging from 6-12 months). Latest OMO data shows SRBI’s outstanding reaching IDR932tr, with about two-thirds held by banks. At present, we have also seen a substantial drop in banks’ reverse repo (i.e. banks’ injecting liquidity into BI) as banks have shifted from reverse repo towards SRBIs (simply because of better yields).

And with weekly SRBI issuances approximating ~IDR17.5tr, we estimate net liquidity injections were ~IDR13tr in 4Q24 (relatively insignificant to the overall liquidity). Further out, this could lead to net liquidity reduction of IDR54tr in 1Q25 before improving to net liquidity addition of IDR38tr in 2Q25 (also insignificant to the overall liquidity). The concerns of potential net liquidity absorption in 1Q25 could deepen during the seasonally tight liquidity period as Indonesia will enter a peak holiday season at the end of Mar25.

Nevertheless, despite potentially still tight liquidity into 2025F, major banks could continue to garner superior loan growth at the expense of mid-to-small banks; thereby, further widening the gap between major banks and mid-to-small banks.

In this note, we also showLDRs and incremental LDRs (which is defined as the ratio of loan growth to deposit growth). Both point to higher ratios, which indicate tight liquidity in the system.

Valuations and risks

BBCA — We derive our TP of IDR13,200 using DuPont analysis with key parameters as follows: a risk-free rate of 6.5%, an equity risk premium of 7.8%, beta of 0.8x and a CAR-adjusted ROAE of 24.5%. Our TP implies 5.4x FY25F P/B (vs current price valuation of 4.2x) and 26.9x FY25F P/E (vs current price valuation of 21.0x). Risks are worsening economic trends, tighter liquidity competition, and/or higher credit cost and opex growth.

BMRI — We derive our TP of IDR8,450 using DuPont methodology. Key parameters are a risk-free rate of 6.5%, an equity risk premium of 7.8%, a CAR-adjusted ROAE of 19.8% and beta of 1.03x. We have also used 2025F book as reference. Our TP implies a 2.5x FY25F P/B and a 12.4x FY25F P/E – compared to current price valuations of a 2.1x and a 10.6x, respectively. Key downside risks are worse-than-expected macroeconomic trends, government intervention, tight liquidity competition, and higher credit cost and opex growth.

BBRI — We derive our TP of IDR6,300 using DuPont methodology, assuming a risk-free rate of 6.5%, an equity risk premium of 7.8%, growth of 10.0%, beta 0.8x and a CAR-adjusted ROAE of 18.0%. We also use 2025F book as reference. The implied multiples at our TP are 2.9x 2025F book and 14.8x 2025F earnings (compared to current multiples of 2.0x and 10.7x, respectively). Key risks to our view are worsening macroeconomic trends, unfavorable regulatory changes, and tighter liquidity competition (which would increase funding cost), and worsening credit quality (which would raise credit costs), and higher opex.

BBNI — We derive our TP of IDR6,600 based on a DuPont analysis, assuming a risk-free rate of 6.5%, an equity risk premium of 7.8%, growth of 8.5%, beta 1.0x and a CAR-adjusted ROAE of 16.5%. We also use 2025F book as reference. The implied multiples at our TP are 1.4x 2025F book and 10.7x 2025F earnings (compared to current multiples of 1.2x and 9.3x, respectively). Key risks to our view are worsening macroeconomic trends, unfavorable regulatory changes, and tighter liquidity competition (which would increase funding cost), and worsening credit quality (which would raise credit costs), and higher opex.

Fig. 1: BI – OMO trends IDR bn

Source: Company data, Verdhana research

 

Fig. 2: BI – SRBI vs reverse repo IDR bn

Source: Company data, Verdhana research

 

Fig. 3: BI – liquidity injection IDR bn

Source: Company data, Verdhana research

 

Fig. 4: Gross SRBI maturities

Source: Company data, Verdhana research
Fig. 5: Net liquidity

Source: Company data, Verdhana research

 

Fig. 6: LDR

Source: Company data, Verdhana research
Fig. 7: 12MMA incremental LDR %

Source: Company data, Verdhana research

 

Fig. 8: Loan to CASA %

Source: Company data, Verdhana research

 

INVESTMENT RATINGS
A rating of ‘Buy’, indicates that the analyst expects the stock to outperform the Benchmark over the next 12 months. A rating of ‘Neutral’, indicates that the analyst expects the stock to perform in line with the Benchmark over the next 12 months. A rating of ‘Reduce’, indicates that the analyst expects the stock to underperform the Benchmark over the next 12 months. A rating of ‘Suspended’, indicates that the rating, target price, and estimates have been suspended temporarily to comply with applicable regulations and/or firm policies. Securities and/or companies that are labelled as ‘Not Rated’ or ‘No Rating’ are not in regular research coverage. Benchmark is Indonesia Composite Index (‘IDX Composite’). A ‘Target Price’, if discussed, indicates the analyst’s forecast for the share price with a 12-month time horizon, reflecting in part of the analyst’s estimates for the company’s earnings, and may be impeded by general market and macroeconomic trends, and by other risks related to the company or the market in general. 

GENERAL DISCLOSURE/DISCLAIMER 
This report is prepared by PT Verdhana Sekuritas Indonesia (“PTVSI”) a securities company registered in Indonesia, supervised by Indonesia Financial Services Authority (OJK) and a member of the Indonesia Stock Exchange (IDX).

This report is intended for client of PTVSI only and no part of this document may be (i) copied, photocopied or duplicated in any form or by any means or (ii) redistributed without the prior written consent of PTVSI.

The research set out in this report is based on information obtained from sources believed to be reliable, but PTVSI do not make any representation or warranty as to its accuracy, completeness or correctness. The information in this report is subject to change without notice, its accuracy is not guaranteed, it may be incomplete or condensed and it may not contain all material information concerning the company (or companies) referred to in this report. Any information, valuations, opinions, estimates, forecasts, ratings or targets herein constitutes a judgment as of the date of this report is published, and there is no assurance that future results or events will be consistent.


This report is not to be construed as an offer or a solicitation of an offer to buy or sell any securities or financial products. PTVSI and its associates, its directors, and/or its employees may from time to time have interests in the securities mentioned in this report or it may or will engage in any securities transaction or other capital market services for the company (companies) mentioned herein.

ANALYST CERTIFICATION
The research analyst primarily responsible for the content of this report and certifies that the views about the companies including their securities expressed in this report accurately reflect his/her personal views.  The analyst also certifies that no part of his/her compensation was, is, or will be, directly, or indirectly, related to specific recommendations or views expressed in this report.


RESTRICTIONS ON DISTRIBUTION

By accepting this report, the recipient hereof represents and warrants that you are entitled to receive such report in accordance with the restrictions and agrees to be bound by the limitations contained herein. Neither this report nor any copy hereof may be distributed except in compliance with applicable Indonesian capital market laws and regulations. 

Nicholas Santoso (nicholas.santoso@verdhana.id) 

Erwin Wijaya (erwin.wijaya@verdhana.id)